These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28209157)

  • 1. Stakeholder perspectives on the implementation of genetic carrier screening in a changing landscape.
    Holtkamp KC; Vos EM; Rigter T; Lakeman P; Henneman L; Cornel MC
    BMC Health Serv Res; 2017 Feb; 17(1):146. PubMed ID: 28209157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors for successful implementation of population-based expanded carrier screening: learning from existing initiatives.
    Holtkamp KCA; Mathijssen IB; Lakeman P; van Maarle MC; Dondorp WJ; Henneman L; Cornel MC
    Eur J Public Health; 2017 Apr; 27(2):372-377. PubMed ID: 27485720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolving landscape of expanded carrier screening: challenges and opportunities.
    Kraft SA; Duenas D; Wilfond BS; Goddard KAB
    Genet Med; 2019 Apr; 21(4):790-797. PubMed ID: 30245516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do people from the Jewish community prefer ancestry-based or pan-ethnic expanded carrier screening?
    Holtkamp KC; van Maarle MC; Schouten MJ; Dondorp WJ; Lakeman P; Henneman L
    Eur J Hum Genet; 2016 Feb; 24(2):171-7. PubMed ID: 25966636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanded Carrier Screening.
    Gregg AR
    Obstet Gynecol Clin North Am; 2018 Mar; 45(1):103-112. PubMed ID: 29428278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of reproductive genetic technologies: Perspectives of professional stakeholders.
    van Dijke I; van El CG; Lakeman P; Goddijn M; Rigter T; Cornel MC; Henneman L
    PLoS One; 2022; 17(6):e0269719. PubMed ID: 35727796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Socioeconomic status and uptake of reproductive carrier screening in Australia.
    Robson SJ; Caramins M; Saad M; Suthers G
    Aust N Z J Obstet Gynaecol; 2020 Dec; 60(6):976-979. PubMed ID: 32748403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advantages of expanded universal carrier screening: what is at stake?
    van der Hout S; Holtkamp KC; Henneman L; de Wert G; Dondorp WJ
    Eur J Hum Genet; 2016 Jan; 25(1):17-21. PubMed ID: 27677414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethnicity-Based Carrier Screening.
    King JR; Klugman S
    Obstet Gynecol Clin North Am; 2018 Mar; 45(1):83-101. PubMed ID: 29428288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre- and post-testing counseling considerations for the provision of expanded carrier screening: exploration of European geneticists' views.
    Janssens S; Chokoshvili D; Vears DF; De Paepe A; Borry P
    BMC Med Ethics; 2017 Aug; 18(1):46. PubMed ID: 28764782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using a theory informed approach to design, execute, and evaluate implementation strategies to support offering reproductive genetic carrier screening in Australia.
    Best S; Long JC; Fehlberg Z; Taylor N; Ellis LA; Boggs K; Braithwaite J
    BMC Health Serv Res; 2023 Nov; 23(1):1276. PubMed ID: 37981708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanded carrier screening: A review of early implementation and literature.
    Lazarin GA; Haque IS
    Semin Perinatol; 2016 Feb; 40(1):29-34. PubMed ID: 26718446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current practice and attitudes of Australian obstetricians toward population-based carrier screening for inherited conditions.
    Stark Z; Massie J; McClaren B; Ioannou L; Cousens N; Lewis S; Metcalfe S; Delatycki MB
    Twin Res Hum Genet; 2013 Apr; 16(2):601-7. PubMed ID: 23331496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceptions of reproductive healthcare providers regarding their involvement in offering expanded carrier screening in fertility clinics: a qualitative study.
    Klein D; van Dijke I; van Langen IM; Dondorp W; Lakeman P; Henneman L; Cornel MC
    Reprod Biomed Online; 2024 Jul; 49(1):103857. PubMed ID: 38643517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possibilities and barriers in the implementation of a preconceptional screening programme for cystic fibrosis carriers: a focus group study.
    Poppelaars FA; van der Wal G; Braspenning JC; Cornel MC; Henneman L; Langendam MW; ten Kate LP
    Public Health; 2003 Nov; 117(6):396-403. PubMed ID: 14522154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health practitioners' perceptions of the barriers and enablers to the implementation of reproductive genetic carrier screening: A systematic review.
    Best S; Long J; Theodorou T; Hatem S; Lake R; Archibald A; Freeman L; Braithwaite J
    Prenat Diagn; 2021 May; 41(6):708-719. PubMed ID: 33533079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
    J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involving the public and other stakeholders in development and evaluation of a community pharmacy alcohol screening and brief advice service.
    Krska J; Mackridge AJ
    Public Health; 2014 Apr; 128(4):309-16. PubMed ID: 24713598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creation of a National, At-home Model for Ashkenazi Jewish Carrier Screening.
    Grinzaid KA; Page PZ; Denton JJ; Ginsberg J
    J Genet Couns; 2015 Jun; 24(3):381-7. PubMed ID: 25502003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is required to facilitate implementation of Swedish physical activity on prescription? - interview study with primary healthcare staff and management.
    Gustavsson C; Nordqvist M; Bröms K; Jerdén L; Kallings LV; Wallin L
    BMC Health Serv Res; 2018 Mar; 18(1):196. PubMed ID: 29562922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.